0001062993-19-004037.txt : 20191025
0001062993-19-004037.hdr.sgml : 20191025
20191025164705
ACCESSION NUMBER: 0001062993-19-004037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191023
FILED AS OF DATE: 20191025
DATE AS OF CHANGE: 20191025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BUCHI J KEVIN
CENTRAL INDEX KEY: 0001209726
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 191170419
MAIL ADDRESS:
STREET 1: 41 MOORES ROAD
CITY: FRAZER
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2019-10-23
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001209726
BUCHI J KEVIN
C/O BIOSPECIFICS TECHNOLOGIES CORP.
35 WILBUR STREET
LYNBROOK
NY
11563
1
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
46.52
2019-10-23
4
A
0
85000
0.00
A
2029-10-23
Common Stock
85000
85000
D
The stock options were granted under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan.
The stock options vest ratably over the four-year period following the date of grant, October 23, 2019, subject to the Reporting Person's continued service to the employer through the vesting date. In the event the Reporting Person is terminated (a) by the employer without cause, (b) by the Reporting Person for good reason, or (c) by the employer without cause or by the Reporting Person for good reason, in each case upon or within one (1) year following a change of control, the stock options will fully vest.
/s/ J. Kevin Buchi, by Carl A. Valenstein, attorney-in-fact
2019-10-25